Dermatologic Therapy · 2011 · 13 citations · 22 references
EngineeringBioengineeringBiotechnologyGene DeliveryMedical BiotechnologyTissue EngineeringGene Delivery SystemsGene Delivery VectorsLocal Gene DeliverySkin Tissue EngineeringTherapeutic Protein EngineeringViral Vector-mediated TransgenesisAdenoviral TransgenesisAdenoviral VectorsEx Vivo DeliveryEx Vivo ModelsGenetic Modification Of VectorsProtein ProductionTherapeutic ProteinsVirally Derived Delivery Vectors
A novel approach for sustained production of therapeutic proteins is described, using genetic modification of intact autologous micro-organ tissue explants from the subject's own skin. The skin-derived micro-organ can be maintained viable ex vivo for extended periods and is transduced with a transgene encoding a desired therapeutic protein, resulting in protein-secreting micro-organ (biopump (BP)). The daily protein production from each BP is quantified, enabling drug dosing by subcutaneous implantation of the requisite number of BPs into the patient to provide continuous production to the circulation of a known amount of the therapeutic protein. Each implanted BP remains localized and is accessible, to enable removal or ablation if needed. Examples from preclinical and clinical studies are presented, including use of associated virus vector 1 and helper-dependent adenoviral vectors producing BPs to provide long-term sustained secretion of recombinant interferon-α and erythropoietin.
22
Núria Morral, Wanda K. O’Neal, Karen Rice et al. · Proceedings of the National Academy of Sciences · 1999 · 410 citations
Improved system for helper-dependent adenoviral vector production
Donna Palmer, Philip Ng · Molecular Therapy · 2003 · 314 citations · Full text